Salani D - Search Results

1

Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation.

Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosanò L, Trisciuoglio D, Spinella F, Bagnato A. Del Bufalo D, et al. Among authors: salani d. Mol Pharmacol. 2002 Mar;61(3):524-32. doi: 10.1124/mol.61.3.524. Mol Pharmacol. 2002. PMID: 11854432

2

Endothelin-1 acts as a survival factor in ovarian carcinoma cells.

Del Bufalo D, Di Castro V, Biroccio A, Salani D, Rosanò L, Spinella F, Bagnato A. Del Bufalo D, et al. Among authors: salani d. Clin Sci (Lond). 2002 Aug;103 Suppl 48:302S-305S. doi: 10.1042/CS103S302S. Clin Sci (Lond). 2002. PMID: 12193109

3

Endothelin-1 promotes proteolytic activity of ovarian carcinoma.

Rosanò L, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A. Rosanò L, et al. Among authors: salani d. Clin Sci (Lond). 2002 Aug;103 Suppl 48:306S-309S. doi: 10.1042/CS103S306S. Clin Sci (Lond). 2002. PMID: 12193110

4

ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.

Salani D, Rosanò L, Di Castro V, Spinella F, Venuti A, Padley RJ, Nicotra MR, Natali PG, Bagnato A. Salani D, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:318S-321S. doi: 10.1042/CS103S318S. Clin Sci (Lond). 2002. PMID: 12193113

5

Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.

Rosanò L, Spinella F, Salani D, Di Castro V, Venuti A, Nicotra MR, Natali PG, Bagnato A. Rosanò L, et al. Among authors: salani d. Cancer Res. 2003 May 15;63(10):2447-53. Cancer Res. 2003. PMID: 12750265

6

Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.

Bagnato A, Salani D, Di Castro V, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A, Natali PG. Bagnato A, et al. Among authors: salani d. Cancer Res. 1999 Feb 1;59(3):720-7. Cancer Res. 1999. PMID: 9973223

7

Role of endothelin-1 in neovascularization of ovarian carcinoma.

Salani D, Di Castro V, Nicotra MR, Rosanò L, Tecce R, Venuti A, Natali PG, Bagnato A. Salani D, et al. Am J Pathol. 2000 Nov;157(5):1537-47. doi: 10.1016/S0002-9440(10)64791-8. Am J Pathol. 2000. PMID: 11073813 Free PMC article.

8

Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells.

Bagnato A, Rosanò L, Di Castro V, Albini A, Salani D, Varmi M, Nicotra MR, Natali PG. Bagnato A, et al. Among authors: salani d. Am J Pathol. 2001 Mar;158(3):841-7. doi: 10.1016/S0002-9440(10)64032-1. Am J Pathol. 2001. PMID: 11238033 Free PMC article.

9

Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

Rosanò L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A. Rosanò L, et al. Among authors: salani d. Cancer Res. 2001 Nov 15;61(22):8340-6. Cancer Res. 2001. PMID: 11719468

10

Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma.

Venuti A, Salani D, Cirilli A, Simeone P, Muller A, Flamini S, Padley R, Bagnato A. Venuti A, et al. Among authors: salani d. Clin Sci (Lond). 2002 Aug;103 Suppl 48:310S-313S. doi: 10.1042/CS103S310S. Clin Sci (Lond). 2002. PMID: 12193111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters